CSIMarket
 
Innovation Pharmaceuticals Inc   (CTIX)
Other Ticker:  
 
 

Innovation Pharmaceuticals Inc Cash flow Statement Quarterly

CTIX



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Sep 30 2023)
3 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
9 Months
(Dec 31 2022)
6 Months
(Sep 30 2022)
3 Months
Income -0.88 -3.17 -2.49 -1.79 -1.43
Depreciation & amortization - - - - -
Amortization of Other Assets 0.09 0.37 0.28 0.19 0.09
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Impairment of Intangible Assets, Finite-lived - - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property - - - - -
Share-based Compensation 0.00 0.21 0.20 0.20 0.18
Income (Loss) from Equity Method Investments 0.06 0.17 - - -
Gains (Losses) on Extinguishment of Debt - - - - -
Issuance Of Stock And Stock Options For Services Compensation Rendered And Charitable Contributions - - - - -
Patent Write Off - - - - -
Interest Expense - - - - -
Write Off Of Deferred Debt Issuance Cost - - - - -
Modification Of Series B Convertible Preferred Stock Terms - - - - -
Interest Expense Debt - - - - -
Change In Fair Value Of Preferred Stock - - - - -
Increase Decrease Operating Leases Liability - -0.14 -0.09 -0.05 -0.12
Allocating Warrants Proportion Of Value Exercised To Pref Stock Liability - - - - -
Operating Lease Impairment Loss - - - - -
Interest Expense Preferred Stock - - - - 0.29
Change In Fair Value Preferred Stock - 0.08 0.05 0.03 -
Increase Decrease In Prepaid Expenses And Other Current Assets 0.04 - - - -
Increase Decrease In Accrued Dividend 0.01 - - - -
Income taxes - - - - -
Gain (Loss) on Investments - - - - -
Increase (Decrease) in Employee Related Liabilities -0.10 0.05 0.05 0.02 0.01
Increase (Decrease) in Accounts Payable 0.04 0.42 0.13 0.13 0.35
Increase (Decrease) in Accrued Liabilities 0.12 -0.02 -0.02 -0.03 0.00
Increase (Decrease) in Security Deposits - - - 0.04 0.02
Increase (Decrease) in Prepaid Expenses, Other - 0.03 - - -
Other Working Capital - - - - -
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities -0.06 0.00 0.17 0.02 -
Discontinued operations - - - - -
Net Cash flow from Operating Activities -0.68 -2.11 -1.74 -1.27 -0.79
Capital Expenditures 0.00 -0.06 - - -
Sale of Capital Items - - - - -
Short-term Investments Proceeds - - - - -
Short-term Investments Acq. - - - - -
Real Estate Investments - - - - -
Additions To Property Plant And Equipment - - - - -
Patent Costs - -0.05 -0.03 0.00 -0.05
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net - - - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities 0.00 -0.06 -0.05 -0.03 0.00
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments 0.03 -0.04 -0.01 -0.02 -0.01
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock - - - - -
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net - - - - -
Proceeds From Issuance Of Common Stock Net Of Offering Costs - - - - -
Proceeds From Deferred Offering Costs - - - - -
Treasury Stock Value Acquired Cost Method - - - - -
Convertible Preferred Stock Converted To Other Securities - - - - -
Excess Of Exercise Price Of Warrants At850950 Over Fair Value Of - - - - -
Sale Of Common Stock Net Of Offering Costs - - - - -
Dividend Paid To Preferred Stockholders - -0.07 -0.07 -0.04 -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 0.03 -0.12 -0.08 -0.09 -0.04
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -0.68 -2.17 -1.74 -1.27 -0.79
Total Cash Flow -0.65 -2.29 -1.87 -1.38 -0.84
Cash & cash equiv. at beg. of the Year - - - - -
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid - - - - -




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com